Lung cancer, the leading cause of cancer-related deaths globally, includes non-small cell lung cancer (NSCLC) (85% of cases) and small cell lung cancer (SCLC) (13–15%). While accurate diagnosis and treatment selection are critical, the absence of reliable predictive or prognostic biomarkers remains a significant challenge. This study explored the combined use of radiomics from CT scans and pathomics from H&E slides in three contexts: (1) predicting disease recurrence in early-stage NSCLC, (2) predicting immunotherapy response in advanced-stage NSCLC, and (3) predicting chemotherapy response in SCLC. The integrated radio-pathomic model significantly outperformed individual models. In early-stage NSCLC (N = 194), it achieved an HR of 8.35 (C-index: 0.71, p = 0.0043). In advanced-stage NSCLC (N = 35), the combined model improved predictive performance (AUC: 0.75, p = 0.042). In SCLC (N = 50), the integrated model showed an AUC of 0.78, surpassing both radiomic and pathomic models. These findings highlight the potential of combining radiomics and pathomics for improved lung cancer risk stratification and treatment prediction.
Read full abstract- All Solutions
Editage
One platform for all researcher needs
Paperpal
AI-powered academic writing assistant
R Discovery
Your #1 AI companion for literature search
Mind the Graph
AI tool for graphics, illustrations, and artwork
Journal finder
AI-powered journal recommender
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus - Support
Overview
14145 Articles
Published in last 50 years
Articles published on Individual Models
Authors
Select Authors
Journals
Select Journals
Duration
Select Duration
13716 Search results
Sort by Recency